Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors Meeting Abstract


Authors: Hyman, D.; Chatterjee, M.; Langenberg, M. H. G.; Lin, C. C.; Suarez, C.; Tai, D.; Cassier, P.; Yamamoto, N.; De Weger, V. A.; Jeay, S.; Meille, C.; Halilovic, E.; Mariconti, L.; Guerreiro, N.; Kumar, A.; Wuerthner, J. U.; Bauer, S.
Abstract Title: Dose- and regimen-finding phase I study of NVP-HDM201 in patients (pts) with TP53 wild-type (wt) advanced tumors
Meeting Title: 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 69
Issue: Suppl. 1
Meeting Dates: 2016 Nov 29-Dec 2
Meeting Location: Munich, Germany
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2016-12-01
Start Page: S128
End Page: S129
Language: English
ACCESSION: WOS:000390503500377
PROVIDER: wos
DOI: 10.1016/S0959-8049(16)32982-3
Notes: Meeting Abstract: 391 -- 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 29-DEC 02, 2016 -- Munich, GERMANY -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Hyman
    354 Hyman